PPARG and diabetes mellitus: Genetic deficit or pharmacological blockade of angiotensin receptor 1 (AT1R) attenuates atherosclerosis and improves endothelial function in experimentally induced diabetes in ApoE−/− mice via peroxisome proli-ferator-activated receptor γ (PPARγ) pathway[24,25].